For instance, a dose of 2.5 μg WIV adjuvanted with cationic lipid/DNA complex (CLDC) was able to induce influenza-specific CD4+ and CD8+ T cell responses in mice, whereas alum adjuvanted WIV only induced high-antibody responses (57). Here, CD4 is linked to influenza.